Financing type:  underwritten prospectus offering

Gross proceeds:  $23,011,500

Offering:  7,935,000 listed shares (including full overallotment option for 1,035,000 listed shares)

Offering price:  $2.90 per listed share

Overallotment option:  The underwriters may purchase a maximum of 1,035,000 listed shares for overallotment purposes. As of Aug. 18, 2026, such option has been exercised and 1,035,000 listed shares have been issued thereunder. All information presented herein includes such exercise.

Disclosure:  Refer to the base shelf prospectus dated Nov. 14, 2025, the prospectus supplement dated Aug. 6, 2026, and the company's news releases dated Aug. 4, 2026, and Aug. 12, 2026.